Vasquez Nicki 4
4 · SUTRO BIOPHARMA, INC. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Vasquez Nicki
Chief Port. Strat & Alnce Ofcr
Transactions
- Exercise/Conversion
Common Stock
2024-01-29+2,500→ 15,303 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-01-29−2,500→ 0 totalExp: 2024-01-29→ Common Stock (2,500 underlying) - Sale
Common Stock
2024-01-29$5.00/sh−12,185$60,925→ 12,803 total - Tax Payment
Common Stock
2024-01-29$4.99/sh−1,024$5,110→ 14,279 total
Footnotes (4)
- [F1]This transaction was entered into pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 29, 2023.
- [F2]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F4]The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.